Mon, 19th Apr 2021 20:40
Proteome Sciences PLC - drug development services provider - Says Non-Executive Director Roger McDowell buys 900,000 shares at 5.00 pence each on Friday in deal worth GBP45,000. As a result, McDowell now holds 3.4 million shares, representing around a 1.2% stake.
Current stock price: 5.75p, up 14% on Monday
Year-to-date change: up 49%
By Lucy Heming;Â lucyheming@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrome...
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's ma...
(Alliance News) - Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon.
(Alliance News) - Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays.
Proteome (PRM)